’Maharashtra is the hub of quality medicines’
Maharashtra still dominates the Indian pharma sector, emphasises Mahesh Zagade, Commissioner, FDA Maharashtra, in conversation…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story Archive
Agenda for the next PM
What policy changes should be on the next Prime Minister's Agenda in order to re-vitalise the pharmaceutical industry in India?…
Healthcare A Poli-Trickal Issue
Indian political parties are busy wooing voters with myriad promises for the General Elections 2014. Yet healthcare, a vital…
Clinical trials in India Uncertainty lingers
As the Indian clinical research industry strives to adhere to the numerous changes announced last year, the delay in clearing up…
Clinical trials: Perception vs reality
As regulators and industry hammer out practical implementation strategies of India's evolving clinical trial regulations, both…
Harnessing Asia’s clinical trial potential
Lisa Marie Saldanha, Director, Head of Site Identification Services Asia, Quintiles and Dr Karen Wai, Senior Director, Head, Site…
Train to Gain
Non compliance with GMP norms has proved costly for some of the biggest Indian pharmaceutical companies. Eager to avoid such…
Initiatives by IDMA
SV Veerramani, President,IDMA, Chairman and Managing Director, Fourrts (India) Laboratories elaborates on endeavours taken by IDMA…
An arduous endeavour?
Indian pharma companies are pushing for 'third country' status from the EU regulatory authorities for India's Schedule M and GMP…
cGMP implementation: From philosophy to practice
Advocating a quality systems approach for cGMP implementation, SM Mudda, Executive Director-Technical & Operations, Micro…